| Symbol | SZLSF |
|---|---|
| Name | STAGEZERO LIFE SCIENCES LTD. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | L4B 3B2 Canada ON 70 East Beaver Creek Rd Unit 30 |
| Telephone | +1 855-420-7140 |
| Fax | — |
| — | |
| Website | https://www.stagezerolifesciences.com |
| Incorporation | CA |
| Incorporated On | 1998 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | SRCO Professional Corporation, Charted Accountant; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: TSX Venture Exchange |
| CIK | 0001454263 |
| Description | StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Companys next-generation test, Aristotle, is the first-ever multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZeros full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. Additional info from OTC: |
No news found.